Cite
HARVARD Citation
Sacilotto, N. et al. (n.d.). Iadademstat and gilteritinib synergistically abrogate viability of both treatment-naïve and drug-resistant AML cells. European journal of cancer. pp. S68-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sacilotto, N. et al. (n.d.). Iadademstat and gilteritinib synergistically abrogate viability of both treatment-naïve and drug-resistant AML cells. European journal of cancer. pp. S68-. [Online].